Search Results

Society of NeuroInterventional Surgery Launches “Get Ahead of Stroke” Campaign

May 25, 2016—The Society of NeuroInterventional Surgery (SNIS) announced a new initiative, the “Get Ahead of Stroke” national public education and advocacy campaign designed to improve systems of care for stroke patients.

Penumbra 3D Stent Retriever Plus Aspiration Trial Meets Primary Endpoints

July 27, 2016—Penumbra, Inc. announced that its 3D stent retriever revascularization device used in conjunction with Penumbra aspiration devices demonstrated noninferior safety and efficacy compared to using Penumbra system aspiration devices alone, meeting the primary endpoints set in the Penumbra 3D trial.

Neurointerventional Training Guidelines Aim to Ensure Optimal Outcomes for Ischemic Stroke Patients

February 24, 2016—The Society of NeuroInterventional Surgery (SNIS) recently announced the release of new multisociety training guidelines for endovascular intervention in ischemic stroke patients.

Standardized Protocol Studied for Timely Treatment of ELVO Stroke Patients

July 24, 2018—Findings from a study presented at the Society of NeuroInterventional Surgery’s (SNIS) 15th Annual Meeting held July 23–26 in San Francisco, California, demonstrated that developing a standardized stroke protocol of neurointerventional teams meeting suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of < 60 minutes.

Societies Respond to Publication of MR CLEAN Trial Data

December 17, 2014—The Society of Neurointerventional Surgery (SNIS) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) have commented on the publication of the MR CLEAN study online in The New England Journal of Medicine, which demonstrated that the addition of intra-arterial clot removal is more effective than intravenous-administered tissue plasminogen activator (IV-tPA, alteplase) therapy alone for the treatment of stroke. On December 22, leaders of the Society of Vascular & Interventional Neurology (SVIN) issued a statement on the MR CLEAN data.

STRATIS Registry Evaluates Efficiency in Stroke Treatment; SNIS Aims to "Get Ahead of Stroke"

July 27, 2016—Findings from the STRATIS registry presented at the Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting in Boston, Massachusetts, found that stroke patients who go directly to an endovascular center could potentially receive treatment 99 minutes earlier.

Codman Neuro Launches Codman Enterprise 2 to Treat Wide-Necked Intracranial Aneurysms

February 16, 2016—Codman Neuro, part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the Codman Enterprise 2 vascular reconstruction device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.

New Generations of Devices Improving Treatment Outcomes for Stroke

July 27, 2015—The Society of NeuroInterventional Surgery (SNIS) announced that two new studies released at the SNIS 12th annual meeting in San Francisco, California, reinforce the value and progress of intra-arterial treatment for stroke.

STRATIS Registry Evaluates Effects of Interhospital Transfer on Stroke Patients Before Thrombectomy

December 13, 2017—Findings from the STRATIS registry were published by Michael T. Froehler, MD, et al in Circulation (2017;136:2311–2321). STRATIS (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) was a prospective, multicenter, observational, single-arm study of real-world mechanical thrombectomy for acute stroke due to anterior circulation large vessel occlusion.

SNIS Lauds ESCAPE and EXTEND-IA Stroke Trials

February 11, 2015—The Society of Neurointerventional Surgery (SNIS) announced that data from the ESCAPE and EXTEND-IA clinical trials studying the treatment of stroke demonstrate that neurointerventional procedures significantly increase the number of patients who are able to live independently without major neurological disabilities.

SEER Meta-Analysis Supports Medtronic's Solitaire Stent Retriever For Acute Ischemic Stroke Treatment

February 23, 2016—Medtronic plc announced that results from the Safety and Efficacy of Solitaire Stent Thrombectomy (SEER)—Individual Patient Data Meta-Analysis of Randomized Trials were presented at the International Stroke Conference, which was held February 17 to 19 in Los Angeles, California.